We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Bacterial Toxin Sets the Course for Infection

By LabMedica International staff writers
Posted on 21 Nov 2013
Various toxins and effector proteins of bacterial pathogens have been found to manipulate eukaryotic cell machineries to promote persistence and proliferation within their hosts.

Some isolates of Yersinia pseudotuberculosis produce the cytotoxic necrotizing factor (CNFγ), but the functional consequences of this toxin for host-pathogen interactions during the infection are unknown.

Scientists at Helmholtz Center for Infection Research (Brunswick, Germany) cultured Yersinia strains in Luria-Bertani (LB) broth at 25 °C or 37 °C. More...
All DNA manipulations, polymerase chain reactions, restriction digestions, ligations, and transformations were performed using standard techniques. The β-galactosidase activity was determined for three independent cultures of bacteria.

Activation of Ras homolog gene family, member A (RhoA) was tested using the Rho activation assay kit (Millipore; Billerica, MA, USA) and activation of ras-related C3 botulinum toxin substrate 1 (Rac1) and cell division control protein 42 homolog (Cdc42) was determined with the Rho/Rac/Cdc42 Activation Assay Combo Kit (Cell Biolabs; San Diego, CA, USA).

In order to elucidate its function, the scientists genetically modified a bacterial strain that usually forms CNFγ in such a way that it lost the ability to produce this factor. They identified the molecular target that CNFγ manipulates, generating the dramatic consequences that involve the so-called small Rho guanosine triphosphate enzymes (GTPases). These enzymes initiate a whole cascade of events, for example alteration of the cytoskeleton. This leads to pores in the host cell surface, through which bacterial syringes can more efficiently transport active agents into the cell. The observed cell mortality of the immune cells is introduced through Rho GTPases as well.

Petra Dersch, PhD, a professor and senior author of the study explained, “We have discovered a very clever strategy of Yersinia pseudotuberculosis. With the aid of CNFγ, the bacterium manipulates the host cell in such a manner that the injection apparatus can work more effectively. It sets the course for an efficient infection and triggers onset of the disease.” The authors concluded that CNFγ is important for pathogenicity by showing that this toxin modulates inflammatory responses, protects the bacteria from attacks of innate immune effectors and enhances the severity of a Yersinia infection. The study was published on November 7, 2013, in the journal Public Library of Science Pathogens.

Related Links:

Helmholtz Centre for Infection Research
Millipore 
Cell Biolabs 



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
New
Blood Gas and Chemistry Analysis System
Edan i500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.